Amgen edges higher to $387.77 ahead of Q2 2026 results announcement, Amgen reports

Traders Union
All News
Business & Wealth
Companies
Amgen trades flat today at $387.77

Highlights

AMGN sustains a strong bullish trend, trading well above multiple moving averages across all timeframes.
Momentum indicators flag overbought conditions, with potential for a near-term pullback despite dominant buyer pressure.
AMGN likely trades between $379 and $397 this week, with breakout potential above $388 and key support at $369–$371.

The company posted a link for further details. The stock trades under the ticker AMGN.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish positioning as moving averages and Ichimoku define strong support

AMGN is trading at $387.77, well above the MA-20 ($368.89), MA-50 ($353.38), and MA-200 ($342.87), confirming bullish momentum across short-, medium-, and long-term trends. The Ichimoku Kijun at $371.75 sits beneath the current price and serves as immediate support.

Overbought momentum as weekly gains prompt pullback risk

Momentum signals remain broadly positive: MACD on D1 gives a clear Buy with no major resistance from ADX, though D1 ADX suggests trend strength is moderate. RSI (67.43), CCI (227.56), and Stoch RSI (74.75) on D1 all indicate overbought conditions, flagging a risk of near-term pullback. BBP shows buyer dominance and confirms upward intraday pressure. The AO also supports the bullish structure. AMGN has risen $11.87 (3.16%) over the past week and is trading in the middle of the weekly range, with weekly volatility at 6.34%. This reflects a strong recovery from earlier lows, with the price consolidating after testing both ends of the recent band.

Upside bias as narrow range and indicators favor continuation

For the coming week, AMGN is expected to fluctuate between $379 and $397, a range reflecting typical volatility anchored well above the 52-week low ($269.77) and just below the yearly high ($398.00). The probability of a price increase is high (80%), while the likelihood of a decline is very low (less than 20%), according to W1 momentum and trend-following indicators (RSI, MACD, MA-50 all Buy on W1). Baseline scenario: price remains within $379–$397 as buying interest steadies. Bullish scenario: a breakout above $388 brings a test of $397–$398. Bearish scenario: a move below $379 could trigger a correction toward $369, with $371–$369 providing clustered near-term and key support.

Previously it was reported that Amgen’s outlook remained constructive, underpinned by positive regulatory momentum and a prevailing bullish trend. This article builds on that perspective by analyzing current market drivers and highlights the importance of monitoring for any shift in sentiment that could signal a move beyond consolidation or trigger a corrective phase.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.